DOI: 10.1055/s-00000054

Pharmacopsychiatry

References

Rodriguez CI, Zwerling J, Kalanthroff E. et al.
Effect of a novel NMDA receptor modulator, rapastinel (formerly GLYX-13), in OCD: proof of concept.

Am J Psychiatry 2016;
173: 1239-1241

Rodriguez CI, Zwerling J, Kalanthroff E. et al.
Effect of a novel NMDA receptor modulator, rapastinel (formerly GLYX-13), in OCD: proof of concept.

Am J Psychiatry 2016;
173: 1239-1241

Download Bibliographical Data

Search in:
Access: